I 
118TH CONGRESS 
1ST SESSION 
H. R. 885 
To direct the Secretary of Health and Human Services and other Federal 
officials to compile into a searchable database information relating to 
Federal support for biomedical research and development, and for other 
purposes. 
IN THE HOUSE OF REPRESENTATIVES 
FEBRUARY 9, 2023 
Mr. DOGGETT (for himself, Ms. BARRAGA´N, Mr. BEYER, Mr. BISHOP of Geor-
gia, Mr. BLUMENAUER, Mr. BOWMAN, Ms. CHU, Mr. CICILLINE, Mr. 
CLEAVER, Mr. COHEN, Mr. COURTNEY, Ms. DEGETTE, Ms. DELAURO, 
Mr. DESAULNIER, Mrs. DINGELL, Mr. ESPAILLAT, Mr. EVANS, Mr. 
GREEN of Texas, Mr. GRIJALVA, Mrs. HAYES, Ms. JAYAPAL, Ms. KAP-
TUR, Mr. KHANNA, Ms. LEE of California, Ms. MENG, Mr. NADLER, Mrs. 
NAPOLITANO, Mr. NEGUSE, Ms. NORTON, Ms. PINGREE, Mr. POCAN, Ms. 
PORTER, Mr. RASKIN, Ms. SCANLON, Ms. SCHAKOWSKY, Mr. TAKANO, 
Mr. THOMPSON of California, Ms. TITUS, Ms. TLAIB, Mr. TONKO, Mr. 
TRONE, Mr. VARGAS, Ms. VELA´ZQUEZ, Ms. WILD, Ms. WILLIAMS of 
Georgia, Mr. KILDEE, and Ms. LEGER FERNANDEZ) introduced the fol-
lowing bill; which was referred to the Committee on Energy and Com-
merce, and in addition to the Committees on Armed Services, Veterans’ 
Affairs, the Judiciary, Ways and Means, and Science, Space, and Tech-
nology, for a period to be subsequently determined by the Speaker, in 
each case for consideration of such provisions as fall within the jurisdic-
tion of the committee concerned 
A BILL 
To direct the Secretary of Health and Human Services and 
other Federal officials to compile into a searchable data-
base information relating to Federal support for bio-
medical research and development, and for other pur-
poses. 
VerDate Sep 11 2014 
21:51 Mar 14, 2023
Jkt 039200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6652
E:\BILLS\H885.IH
H885
pbinns on DSKJLVW7X2PROD with $$_JOB
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Taxpayer Research 
And Contributions Knowledge Act of 2023’’ or the 
‘‘TRACK Act of 2023’’. 
SEC. 2. DATABASE. 
(a) IN GENERAL.—The Secretary of Health and 
Human Services, the Director of the National Institutes 
of Health, the Assistant Secretary for Preparedness and 
Response of the Department of Health and Human Serv-
ices, the Director of the Biomedical Advanced Research 
and Development Authority, the Secretary of Defense, the 
Secretary of Veterans Affairs, the Director of the National 
Institute of Allergy and Infectious Diseases, and such 
other Federal officials as the Secretary of Health and 
Human Services determines to be relevant, acting in co-
ordination, shall— 
(1) compile into a searchable database informa-
tion relating to Federal support (before or after the 
date of enactment of this Act) for biomedical re-
search and development; and 
(2) make such database available on the public 
website of the Department of Health and Human 
Services. 
VerDate Sep 11 2014 
21:51 Mar 14, 2023
Jkt 039200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H885.IH
H885
pbinns on DSKJLVW7X2PROD with $$_JOB
(b) COVERED INFORMATION.—The information relat-
ing to Federal support described in subsection (a)(1) in-
cludes all contracts, funding agreements, licensing ar-
rangements, other transactions, and other arrangements 
entered into by, or on behalf of, the Federal Government 
and tax benefits provided with respect to research and de-
velopment, and manufacturing, of a drug (including a bio-
logical product), cell or gene therapy, or medical device 
intended to be manufactured, used, designed, developed, 
modified, repurposed, licensed, or procured to diagnose, 
mitigate, prevent, treat, or cure any disease or condition, 
including the following: 
(1) Licensing agreements pursuant to section 
207 or 209 of title 35, United States Code. 
(2) Cooperative research and development 
agreements and licensing agreements pursuant to 
section 12 of the Stevenson-Wydler Technology In-
novation Act of 1980 (15 U.S.C. 3710a). 
(3) Funding agreements, as defined in section 
201 of title 35, United States Code. 
(4) Transactions, contracts, grants, cooperative 
agreements, other agreements, and other arrange-
ments entered into pursuant to the following stat-
utes: 
VerDate Sep 11 2014 
21:51 Mar 14, 2023
Jkt 039200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H885.IH
H885
pbinns on DSKJLVW7X2PROD with $$_JOB
(A) The Public Health Service Act (42 
U.S.C. 201 et seq.), including sections 301, 
319L, 421, and 480 of such Act (42 U.S.C. 
241, 247d–7e, 285b–3, 287a). 
(B) Section 105 of the National Institutes 
of Health Reform Act of 2006 (42 U.S.C. 
284n). 
(C) Chapter 301 of title 10, United States 
Code, including sections 4001, 4021, 4022, 
4026, and 4023. 
(5) Grants, contracts, and other transactions 
pursuant to section 4021, 4022, or 4026 of title 10, 
United States Code. 
(6) Procurement contracts and other agree-
ments pursuant to section 4023 of title 10, United 
States Code. 
(c) INFORMATION REQUIRED.—Notwithstanding any 
other provision of law, the Federal officials described in 
subsection (a) shall include in the database under sub-
section (a), with regard to each contract, funding agree-
ment, licensing agreement, other transaction, other ar-
rangement, or tax benefit described in subsection (b), at 
least the following information: 
VerDate Sep 11 2014 
21:51 Mar 14, 2023
Jkt 039200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H885.IH
H885
pbinns on DSKJLVW7X2PROD with $$_JOB
(1) The agency, program, institute, or other 
Federal Government entity providing the Federal 
grant, cooperative agreement, or other support. 
(2) The amount and period of Federal financial 
support with an itemized breakdown. 
(3) Other Federal nonfinancial support, includ-
ing the use of Federal personnel, Federal facilities, 
and Federal equipment. 
(4) The grant number, if applicable. 
(5) Associated clinical trial data, upon trial 
completion. 
(6) Associated patents and patent applications, 
specifying— 
(A) any Federal ownership in such patents 
and patent applications; 
(B) the expiration date of such patents 
and filing dates of such patent applications; and 
(C) the numbers of such patents and pat-
ent applications. 
(7) Associated periods of marketing exclusivity 
under Federal law and the durations of such peri-
ods. 
(8) The corporation, nonprofit organization, 
academic institution, person, or other entity receiv-
ing the Federal support. 
VerDate Sep 11 2014 
21:51 Mar 14, 2023
Jkt 039200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H885.IH
H885
pbinns on DSKJLVW7X2PROD with $$_JOB
(9) Any products (including repurposed prod-
ucts) approved, authorized, or cleared for marketing, 
or for which marketing approval, authorization, or 
clearance is being sought, the development of which 
was aided by Federal support, including— 
(A) the names of such products; 
(B) the prices of such products; and 
(C) the current and anticipated manufac-
turing capacity to produce such products. 
(10) The full terms of the contract, funding 
agreement, licensing agreement, other transaction, 
or other arrangement described in subsection (b). 
(d) FORMAT OF INFORMATION.—The database under 
subsection (a) shall be— 
(1) searchable and filterable according to the 
categories of information described in subsection (c); 
and 
(2) presented in a user-friendly format. 
(e) TIMING.—The database under subsection (a) 
shall be— 
(1) made publicly available not later than 1 
month after the date of enactment of this Act; and 
(2) updated not less than every 2 weeks. 
(f) DISCLOSURE.— 
VerDate Sep 11 2014 
21:51 Mar 14, 2023
Jkt 039200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H885.IH
H885
pbinns on DSKJLVW7X2PROD with $$_JOB
(1) IN GENERAL.—Notwithstanding any other 
provision of law, to the extent necessary for an offi-
cial described in subsection (a) to carry out this sec-
tion, such official may require entities receiving Fed-
eral support described in subsection (a)(1) to dis-
close to the official any information relating to such 
Federal support and required to be included in the 
database under subsection (a). 
(2) INTERMEDIARY
COOPERATION.—Any ar-
rangement entered into by the Federal Government 
with an entity providing for such entity to enter into 
contracts, licensing agreements, grants, other trans-
actions, or other arrangements with third parties on 
behalf of the Federal Government shall require such 
entity to disclose in a timely manner any informa-
tion necessary for the Federal Government to fulfill 
its duties under this Act. With respect to any such 
arrangement in place as of the date of enactment of 
this Act, an official described in subsection (a) may 
require the entity to disclose to the official any infor-
mation required to be included in the database 
under subsection (a). 
(3) PENALTY FOR NONDISCLOSURE.—If an en-
tity that is required to disclose information pursuant 
to paragraph (1) or (2) fails to disclose such infor-
VerDate Sep 11 2014 
21:51 Mar 14, 2023
Jkt 039200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H885.IH
H885
pbinns on DSKJLVW7X2PROD with $$_JOB
mation by the date that is 2 weeks after the date on 
which the official requests such information, or by 
such reasonable deadline as the official may specify, 
whichever is sooner, then such entity shall be liable 
to the United States for a civil penalty in an amount 
not to exceed $10,000 for each day on which such 
failure continues. 
Æ 
VerDate Sep 11 2014 
21:51 Mar 14, 2023
Jkt 039200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6301
E:\BILLS\H885.IH
H885
pbinns on DSKJLVW7X2PROD with $$_JOB